Remedi Revenue
Pharmaceutical Manufacturing • 
Korea, Republic of • 1-10 Employees
$
Remedi revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at Remedi
Chanho Park
CEO, Co-founder
Company overview
| Headquarters | Korea, Republic of |
| Website | |
| NAICS | 3254 |
| Keywords | Peptide, Cell Penetrating Peptide, New Drug Development, Senolytic |
| Founded | 2020 |
| Employees | 1-10 |
About Remedi
Innovative CPP(Cell Penetration Peptide)-based Drug Development Company.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
Remedi has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Remedi has never raised funding before.
United States
Brazil
Australia
United Kingdom
Canada
Frequently asked questions
Remedi is located in KR.
Remedi generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.
Remedi has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Remedi was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.
Remedi has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
